Two
isozymes of
11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) interconvert active
cortisol and inactive
cortisone.
11 beta-HSD2 (renal) acts only as a
dehydrogenase, converting
cortisol to
cortisone. 11 beta-HSD1 (liver) is a bi-directional
enzyme in cell homogenates, whereas in intact cells it typically displays oxo-
reductase activity, generating
cortisol from
cortisone. We recently established that
cortisone reductase deficiency is a digenic disease requiring mutations in both the gene encoding 11 beta-HSD1 and in the gene for a novel
enzyme located within the lumen of the endoplasmic reticulum (ER),
hexose-6-phosphate dehydrogenase (H6PDH). This latter
enzyme generates
NADPH, the co-factor required for oxo-
reductase activity. Therefore, we hypothesized that H6PDH expression may be an important determinant of 11 beta-HSD1 oxo-
reductase activity. Transient transfection of chinese hamster ovary (CHO) cells with 11 beta-HSD1 resulted in the appearance of both oxo-
reductase and
dehydrogenase activities in intact cells. Co-transfection of 11 beta-HSD1 with H6PDH increased oxo-
reductase activity whilst virtually eliminating
dehydrogenase activity. In contrast, H6PDH had no effect on reaction direction of
11 beta-HSD2, nor did the cytosolic
enzyme,
glucose-6-phosphate dehydrogenase (G6PD) affect 11 beta-HSD1 oxo-
reductase activity. Conversely in HEK 293 cells stably transfected with 11 beta-HSD1
cDNA, transfection of an H6PDH
siRNA reduced 11 beta-HSD1 oxo-
reductase activity whilst simultaneously increasing 11 beta-HSD1
dehydrogenase activity. In human omental preadipocytes obtained from 15 females of variable body mass index (BMI), H6PDH
mRNA levels positively correlated with 11 beta-HSD1 oxo-
reductase activity, independent of 11 beta-HSD1
mRNA levels. H6PDH expression increased 5.3-fold across adipocyte differentiation (P < 0.05) and was associated with a switch from 11 beta-HSD1
dehydrogenase to oxo-
reductase activity. In conclusion, H6PDH is a crucial determinant of 11 beta-HSD1 oxo-
reductase activity in intact cells. Through its interaction with 11 beta-HSD1, H6PDH may represent a novel target in the pathogenesis and treatment of
obesity.